[
  {
    "rationale": "States dizziness occurred only during first weeks of therapy and is now resolved, matching criterion exactly.",
    "satisfaction": 95.0,
    "score": 14.25
  },
  {
    "rationale": "Captures phone-alarm use and tendency to ignore alarms when busy at work, reflecting adherence challenges; slight lack of explicit mention of \"unpredictable schedule.\"",
    "satisfaction": 85.0,
    "score": 17.0
  },
  {
    "rationale": "Provides clinician advice for pill organizer/alternate reminder but omits explicit documentation of patient agreement.",
    "satisfaction": 60.0,
    "score": 9.0
  },
  {
    "rationale": "Does not specify levetiracetam 500 mg or continued use; only vague reference to \"medication.\"",
    "satisfaction": 10.0,
    "score": 1.0
  },
  {
    "rationale": "No counseling about seizure risk or mitigation steps documented.",
    "satisfaction": 0.0,
    "score": 0.0
  },
  {
    "rationale": "No follow-up or monitoring plan for epilepsy included.",
    "satisfaction": 0.0,
    "score": 0.0
  },
  {
    "rationale": "No unsupported clinical details were introduced in the note.",
    "satisfaction": 95.0,
    "score": 9.5
  },
  {
    "rationale": "Note is concise with no redundant or copy-pasted sections.",
    "satisfaction": 90.0,
    "score": 4.5
  }
]